newsfilter
← Latest News
GlobeNewswire·

NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing

ZURICH, Switzerland, July 31, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (NASDAQ:NCEL), a clinical-stage biopharmaceutical company developing stem cell-based therapies for type 1 diabetes, today announced that it has